Intermedical Care and Lab Hospital PCL (BKK:IMH)
Thailand · Delayed Price · Currency is THB 2.920
-0.020 (-0.68%)
May 25, 2026, 4:37 PM ICT
BKK:IMH Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 759.87 | 754.92 | 756.05 | 669.61 | 639.83 | 942.64 |
Other Revenue | 7.21 | 8.64 | 7.16 | 7.04 | 11.37 | 10.25 |
| 767.08 | 763.56 | 763.21 | 676.65 | 651.2 | 952.88 | |
Revenue Growth (YoY) | -3.82% | 0.05% | 12.79% | 3.91% | -31.66% | 292.87% |
Cost of Revenue | 634.96 | 653.26 | 618.13 | 430.68 | 304.85 | 315.55 |
Gross Profit | 132.12 | 110.3 | 145.08 | 245.97 | 346.36 | 637.34 |
Selling, General & Admin | 144.9 | 148.45 | 152.53 | 143.73 | 124.31 | 105.78 |
Other Operating Expenses | 86.23 | 88 | 37.66 | 35.02 | - | - |
Operating Expenses | 231.13 | 236.45 | 190.19 | 178.75 | 124.31 | 105.78 |
Operating Income | -99.01 | -126.15 | -45.11 | 67.23 | 222.05 | 531.56 |
Interest Expense | -55.04 | -56.78 | -66.58 | -36.49 | -10.82 | -8.75 |
EBT Excluding Unusual Items | -154.05 | -182.94 | -111.69 | 30.74 | 211.23 | 522.8 |
Pretax Income | -154.05 | -182.94 | -111.69 | 30.74 | 211.23 | 522.8 |
Income Tax Expense | 17.75 | 11.62 | -5.15 | 11.98 | 38.12 | 100.1 |
Earnings From Continuing Operations | -171.8 | -194.55 | -106.54 | 18.76 | 173.1 | 422.7 |
Minority Interest in Earnings | 5.72 | 5.86 | 6.76 | 0.33 | 0.01 | - |
Net Income | -166.09 | -188.69 | -99.78 | 19.09 | 173.11 | 422.7 |
Net Income to Common | -166.09 | -188.69 | -99.78 | 19.09 | 173.11 | 422.7 |
Net Income Growth | - | - | - | -88.97% | -59.05% | - |
Shares Outstanding (Basic) | 233 | 227 | 214 | 214 | 214 | 215 |
Shares Outstanding (Diluted) | 233 | 227 | 214 | 214 | 214 | 215 |
Shares Change (YoY) | 8.89% | 6.21% | - | 0.00% | -0.34% | -0.12% |
EPS (Basic) | -0.71 | -0.83 | -0.47 | 0.09 | 0.81 | 1.97 |
EPS (Diluted) | -0.71 | -0.83 | -0.47 | 0.09 | 0.81 | 1.97 |
EPS Growth | - | - | - | -88.97% | -58.91% | - |
Free Cash Flow | 104.74 | 125.34 | 90.45 | 65.49 | 38.64 | 337.67 |
Free Cash Flow Per Share | 0.45 | 0.55 | 0.42 | 0.31 | 0.18 | 1.57 |
Dividend Per Share | - | - | - | - | 0.140 | 0.900 |
Dividend Growth | - | - | - | - | -84.44% | - |
Gross Margin | 17.22% | 14.45% | 19.01% | 36.35% | 53.19% | 66.88% |
Operating Margin | -12.91% | -16.52% | -5.91% | 9.93% | 34.10% | 55.78% |
Profit Margin | -21.65% | -24.71% | -13.07% | 2.82% | 26.58% | 44.36% |
Free Cash Flow Margin | 13.65% | 16.41% | 11.85% | 9.68% | 5.93% | 35.44% |
EBITDA | -65.66 | -92.15 | -8.68 | 100.27 | 245.8 | 552.88 |
EBITDA Margin | -8.56% | -12.07% | -1.14% | 14.82% | 37.75% | 58.02% |
D&A For EBITDA | 33.35 | 34 | 36.43 | 33.05 | 23.75 | 21.32 |
EBIT | -99.01 | -126.15 | -45.11 | 67.23 | 222.05 | 531.56 |
EBIT Margin | -12.91% | -16.52% | -5.91% | 9.93% | 34.10% | 55.78% |
Effective Tax Rate | - | - | - | 38.97% | 18.05% | 19.15% |
Revenue as Reported | 767.08 | 763.56 | 763.21 | 676.65 | 651.2 | 952.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.